<strong>Will MDMA-Assisted Therapy for PTSD be approved in 2024?</strong>
Below is a reprint of a major news release from MAPS, an organization that was solely responsible for the FDA MDMA-Assisted Therapy research.
MAPS PBC No Longer a Public Benefit Corporation
The Multidisciplinary Association for Psychedelic Studies (MAPS) has been admirably resistant to the pressures of the market economy for a long time. But the capital have won, again, and in a somewhat sad move, MAPS’s pharmaceutical arm, the MAPS Public Benefit Corporation, has now become a conventionally structured pharmacological company called Lykos Pharmaceutical.
Rick Doblin is 70
Rick Doblin just turned 70, and I am writing this blog post to share my appreciation and respect for this man.
“Safety: MDMA-Assisted Therapy 101″ with Darek Dawda – MDMA THERAPY PODCAST #18
In this third part of the MDMA-Assisted Therapy series, Dr. Darek Dawda reviews numerous topics related to safety. He argues that, given the nature of this therapy, extra emphasis on safety is of utmost importance, and that some aspects of safety, such as what happens after the dosing sessions, require much more attention than they have received to date. The importance of extended Informed Consent is emphasized.
MAPS just filed an FDA application for MDMA-Assisted Therapy for PTSD – and ETI is starting an MDMA-AT training groups for local Health Care Professionals
After years-long research journey, MAPS PBC just filed an FDA application for the
approval of MDMA-assisted therapy for PTSD. This is the first such application for any
Psychedelic-Assisted Therapy!!!
“MDMA Assisted Therapy 2024” with Rick Doblin – MDMA THERAPY PODCAST #17
Darek Dawda in conversation with Rick Doblin, a legendary visionary who founded MAPS, and who is just about to make one of the most effective known psychotherapies legally available for medical therapeutic use. Rick talks about his journey, the power of MDMA-Assisted Therapy, his thoughts on the future of humankind, and much more.
“Integration: MDMA-Assisted Therapy 101″ with Darek Dawda – MDMA THERAPY PODCAST #16
In this second part of the MDMA-Assisted Therapy series, Dr. Darek Dawda discusses some key concepts related to the process of integration.
“How MDMA-Assisted Therapy reopens critical period for bonding” with Gül Dölen – MDMA THERAPY PODCAST #15
Gül’s work is essential for understanding why MDMA-Assisted Therapy is so capable of helping us learn how to love. In this episode, she explains that the critical window for social bonding can be reopened only if BOTH the drug AND the corrective relational experience are present. Hence, the therapeutic context is key to MDMA’s therapeutic benefit. Gül discusses a host of other ideas essential for understanding MDMA-Assisted Therapy.
Gül is a neuroscientist at Johns Hopkins University. She has published in the most prestigious academic journals, including Neuron, Nature, and Science.
Breaking News: MAPS’ final FDA approval study confirms that MDMA-Assisted Therapy is safe and effective
In a big step towards the legalization of MDMA-Assisted Therapy, Nature Medicine just published the results from the final study required by the FDA before the culmination of the MDMA-AT approval process.
“Introduction: MDMA-Assisted Therapy 101″ with Darek Dawda – MDMA THERAPY PODCAST #14
In this introduction to MDMA-Assisted Therapy, Dr. Darek Dawda discusses a few key concepts necessary for the understanding of this novel therapy.
